Urological Cancer

The Urology group aims to oversee, support and bring together the viewpoints of all of the multi-disciplinary teams working in urology cancer services across the Network. The group also aims to ensure the same standard of care and treatment for patients with urological cancer across the Network.

The Group Lead is: Mr Jeremy Crew, Consultant Urological Surgeon, Oxford University Hospitals NHS Trust

Group Meetings:

The next Group meeting is scheduled for Thursday 28th February 2019 10:00-12:00, location TBC.

Protocols and Guidelines for Urology are listed below:

Whilst every effort is made to ensure the accuracy of the information in a given regimen it cannot be guaranteed that the regimen is fully up to date, because of the dynamic nature of cancer treatment.

• COVID-19 Enzalutamide newly diagnosed metastatic (PDF)
• COVID-19 Atezolizumab 28 day (PDF)
• Urology 4.2 February 2021
• Interim Ipilimumab Nivolumab renal regimen

For further information please contact us using our contact us page.